THOMPSON KIMBERLY KRAIG (CEO, CFO) sold 0.1% of their position (170K shares) of KRAIG BIOCRAFT LABORATORIES, INC. on the open market
Insider sale on the open market — a minor trim. Check remaining position size for full context.
S · 2 sales
Filed: 7/21/2022ACC: 0001493152-22-020038
DirectorOfficer10% Owner· CEO, CFO
Since Dec 2020
-170K
Net shares
Net seller
$0.00
Total acquired
2
Open market trades
0B · 2S
2
Total transactions
170K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−50K
Price / share
—
Trade value
—
% of position
0.0%
7/19/2022
201.76M→201.71M
Common Stock
Direct
Shares
−120K
Price / share
—
Trade value
—
% of position
0.1%
7/20/2022
201.71M→201.59M
Total
Net shares
−170K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/19/2022 | S · Sale | −50K | — | — | 0.0% | 201.76M | 201.71M |
| Common Stock Direct | 7/20/2022 | S · Sale | −120K | — | — | 0.1% | 201.71M | 201.59M |
| Total | −170K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported